Previous Article | Next Article 
Journal of Clinical Microbiology, January 1999, p. 165-170, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Rapid Identification of up to Three
Candida Species in a Single Reaction Tube by a 5'
Exonuclease Assay Using Fluorescent DNA Probes
Jong Hee
Shin,1
Frederick S.
Nolte,2
Brian P.
Holloway,3 and
Christine J.
Morrison4,*
Department of Clinical Pathology, Chonnam
University Medical School, Kwangju, Korea,1 and
Department of Clinical Laboratory Medicine, Emory University
Hospital,2 and
Scientific Resources
Program3 and
Division of Bacterial and
Mycotic Diseases,4 National Center for
Infectious Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia
Received 3 August 1998/Returned for modification 3 September
1998/Accepted 15 October 1998
 |
ABSTRACT |
We used fungus-specific PCR primers and species-specific DNA probes
to detect up to three Candida species in a single reaction tube by exploiting the 5' to 3' exonuclease activity of Taq
DNA polymerase. Probes to the internal transcribed spacer region of the
rRNA gene were labeled at the 5' end with one of three fluorescent reporter dyes, 6-carboxy-fluorescein (FAM),
tetrachloro-6-carboxy-fluorescein (TET), or
hexachloro-6-carboxy-fluorescein (HEX), and at the 3' end with a
quencher dye, 6-carboxy-tetramethyl-rhodamine. During PCR
amplification, each reporter dye emits a characteristic wavelength as
it is cleaved from its specific target DNA and from the quencher dye.
Therefore, signals from up to three probes can be detected simultaneously during the PCR assay. Six probes were designed for use
in this study: CA-FAM, CT-TET, and CP-HEX were added to one tube to
simultaneously detect the typically fluconazole-sensitive species
C. albicans, C. tropicalis, and C. parapsilosis, respectively. CG-FAM and CK-TET were added to a
second tube to simultaneously detect the typically more innately
fluconazole-resistant species C. glabrata and C. krusei, respectively. All-CAN-TET, a Candida genus
probe, was added to a third tube to detect DNAs from all Candida species tested. DNAs recovered from 61 blood
culture bottles, including 23 positive for C. albicans, 18 positive for C. glabrata, 6 positive for C. tropicalis, 6 positive for C. krusei, 5 positive for
C. parapsilosis, and 3 positive for mixed fungemias, were tested. Control samples included those from blood culture bottles with
no growth (n = 10) or from patients with confirmed
bacteremia (n = 10). Probes detected and correctly
identified the organisms in 58 of 61 specimens (95.1%) and gave no
false-positive results. This method is simple and rapid and does not
require post-PCR hybridization and incubation steps. It is sensitive
and specific for the detection and identification of
Candida species from blood culture bottles, including those
containing mixtures of Candida species, and should
facilitate an earlier specific diagnosis, leading to more appropriately
targeted antifungal drug therapy.
 |
INTRODUCTION |
Rapid identification of
Candida species has become particularly important because of
the increase in the numbers of infections caused by newly emerging
species (1, 2, 31, 32). Although not conclusively
determined, it has been suggested that this increase in infections
caused by more innately fluconazole-resistant Candida species such as C. glabrata (18, 33) and C. krusei (31, 32) may be a direct result of the
widespread use of fluconazole for the prophylaxis and treatment of
candidiasis (18, 20, 33). Rapid species identification is
therefore required for appropriate targeting of antifungal drug therapy
and an optimal therapeutic outcome (18, 20, 22, 24).
Whereas C. albicans can be presumptively identified by germ
tube formation tests, C. albicans, C. krusei, and
C. tropicalis can be presumptively identified by growth on
CHROMagar medium, and other species of Candida can be
identified by rapid (4-h) enzymatic tests, each of these procedures
requires that the organism be grown on solid medium for at least
24 h and, more often, for 48 h before such tests can be
performed or their results interpreted (19, 29). In
addition, not all C. albicans isolates form germ tubes, and
the newly described species, C. dubliniensis, which has been
reported to develop a drug-resistant phenotype more rapidly than
C. albicans, is germ tube and chlamydospore positive
(26). The "gold standard" for definitive yeast
identification requires further analysis by assimilation and
fermentation tests, which can require up to 28 days to complete
(29). Therefore, a definitive test for the rapid
identification of Candida isolates to the species level
would be clinically and epidemiologically important.
We previously described a clinically useful PCR-based method for the
rapid detection and identification of Candida species isolates from positive blood culture bottles (25). This
consisted first of a simple DNA extraction procedure with heat,
detergent, and mechanical breakage of cells that did not require the
use of expensive enzymes or phenol-chloroform. A simple, rapid, and sensitive microtitration plate format and colorimetric detection of
digoxigenin-labeled species-specific probes were then used (9,
25). Here we describe a more rapid method in which a 5'
exonuclease assay and fluorescent DNA probes are used (10, 14). The method can be used to differentiate simultaneously up to
three Candida species in a single reaction tube.
Together with the increased specificity afforded by this method (i.e.,
unless the probe binds to a specific, complementary target DNA, no
signal will be generated), this method reduces the PCR cycling time by
using two-step PCR cycling rather than traditional three-step PCR
cycling and eliminates additional post-PCR hybridization by using
fluorescent DNA probes that anneal to the target DNA during the
amplification step. Thus, the total reaction time required for
definitive species identification is reduced to 5 h by the 5'
exonuclease method.
 |
MATERIALS AND METHODS |
Clinical samples.
A total of 81 samples from blood cultured
in BacT/Alert bottles (Organon Teknika Corporation, Durham, N.C.) were
tested: 61 for patients with candidemia, 10 for patients with
bacteremia, and 10 for patients whose bottles had no growth. Twenty
milliliters of blood from each patient with suspected bacteremia or
fungemia was collected at the bedside, and 10 ml was immediately
inoculated into each aerobic and anaerobic BacT/Alert bottle for
culture. The inoculated bottles were agitated continuously in the
BacT/Alert instrument (Organon Teknika Corporation) at a rate of 68 cycles per min and were incubated at 35 to 37°C for 5 days or until
the bottles were positive by colorimetric detection of CO2.
Aliquots from positive bottles were Gram stained and subcultured.
Bottles suspected of containing Candida spp. by Gram
staining were selected, and 2-ml aliquots were removed and stored at
30°C. During the study period, Candida spp. were
isolated from 61 blood culture bottles containing samples from 24 patients. Of 61 bottle sets from which Candida spp. were
isolated, C. albicans blastoconidia were isolated from 23 bottles, C. glabrata was isolated from 18 bottles, C. tropicalis was isolated from 6 bottles, C. krusei was
isolated from 6 bottles, C. parapsilosis was isolated from 5 bottles, and both C. glabrata and C. albicans
were isolated from 3 bottles. Isolates were identified by conventional
sugar fermentation and assimilation tests and by germ tube and
chlamydospore formation (29). Ten randomly selected samples
from patients with bacteremia due to coagulase-negative
Staphylococcus (n = 2),
Enterococcus spp. (n = 2), Citrobacter
freundii (n = 2), Corynebacterium spp.
(n = 2), or a mixture of Enterococcus spp.
and Staphylococcus aureus (n = 1) or
Klebsiella pneumoniae and Acinetobacter
calcoaceticus (n = 1) were also tested as negative
controls. Clinical specimens which never became positive during
incubation (n = 10) were also tested as negative controls.
In addition to clinical samples, BacT/Alert bottles spiked with
C. albicans B311 at 0, 101, 102,
103, 104, and 105 blastoconidia per
200 µl of rabbit whole blood were tested (broth to rabbit blood
ratio, 8:1). The specificities of the DNA probes were also tested
against purified DNA from various bacteria, other fungi, or a human
placental cell line (9).
Extraction of DNA.
A previously described mechanical
disruption method (25) was used for DNA extraction. Briefly,
200 µl of sample was added to 800 µl of TXTE buffer (10 mM Tris, 1 mM EDTA [pH 8.0], 1% Triton X-100) in a sterile, 1.5-ml centrifuge
tube, and the mixture was incubated for 10 min at room temperature.
After lysis, cell debris and Candida blastoconidia were
pelleted by centrifugation at 14,000 rpm for 5 min (centrifuge model
5403; Eppendorf, Engelsdorf, Germany). After three washes by
centrifugation with 1 ml of TXTE buffer, the pellet was resuspended in
300 µl of TXTE buffer and the mixture was transferred to a 2-ml
screw-cap, conical-bottom tube containing 200 µl of 0.5-mm-diameter
zirconium beads (Biospec Products, Bartlesville, Okla.). After boiling
for 15 min, the mixture was shaken for 20 min in a mechanical cell
disrupter (Mini-Beadbeater; Biospec Products). After centrifugation for
20 s, the supernatant was stored at
20°C until it was used for
PCR amplification.
Purified DNA.
Purified DNAs from isolates of C. albicans, C. tropicalis, C. parapsilosis,
C. glabrata, and C. krusei were used as template standards for each PCR. These DNAs and purified DNAs from other Candida species, Saccharomyces cerevisiae,
Cryptococcus neoformans, Aspergillus fumigatus,
Aspergillus flavus, Penicillium marneffei, Histoplasma capsulatum, Blastomyces dermatitidis,
Staphylococcus aureus, Escherichia coli,
Pseudomonas aeruginosa, and a human placental cell line were
obtained by mechanical breakage or enzymatic lysis followed by ethanol
precipitation and phenol-chloroform extraction by conventional means as
described previously (9, 15, 16). All strains of
microorganisms used in the study except for C. kefyr WO696
were described previously (9, 25); C. kefyr was
obtained from the Mycology Reference Laboratory Culture Collection,
Centers for Disease Control and Prevention.
Fluorescent probe design and synthesis.
Probes consisted of
oligonucleotides labeled at their 5' ends with one of three available
fluorescent reporter dyes: 6-carboxy-fluorescein (FAM),
tetrachloro-6-carboxy-fluorescein (TET), or
hexachloro-6-carboxy-fluorescein (HEX) (10, 14). The probes
also contained a quencher dye, 6-carboxy-tetramethyl-rhodamine (TAMRA),
attached to a linker arm-modified nucleotide near the 3' end and a
3'-blocking phosphate (10, 14). Reporter dye fluorescence
was suppressed by the quencher dye during specific binding of the probe
to complementary DNA. Fluorescence was then generated as the probe was
cleaved by the 5' exonuclease activity of the Taq polymerase
during the PCR (10, 14). The six probes used in this study
are listed in Table 1: All-CAN-TET for
the detection of all the DNAs of Candida species and CA-FAM,
CT-TET, CP-HEX, CG-FAM, and CK-TET for the detection of C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, and C. krusei DNAs, respectively.
PCR assay.
The PCR assay was performed with the universal
fungal primers ITS3 and ITS4 (9, 30) and by a standard PCR
protocol (9) modified by the addition of fluorescent probes
(10, 14). Based upon the guanine-plus-cytosine content, the
predicted melting temperatures (Tms) of the
probes for all Candida spp. and C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, and C. krusei were 80, 70, 70, 70, 76, and
72°C, respectively. On the other hand, the Tms
of primers ITS3 and ITS4 were 62 and 58°C, respectively. Therefore,
the probes were redesigned from those reported previously (9,
25) to optimize primer extension and to allow multiple probes to
bind with similar frequencies when they are mixed in one reaction tube
(Table 1). PCR was performed with a 1-µl sample in a total volume of
50 µl containing 10 mM Tris-HCl, 50 mM KCl (pH 8.3), 3.5 mM
MgCl2, dATP, dGTP, dCTP, and dTTP each at a concentration of 0.2 mM, each primer (ITS3 and ITS4) at a concentration of 0.2 µM,
2.5 U of Taq DNA polymerase (Boehringer Mannheim,
Indianapolis, Ind.), and one, two, or three fluorescent probes (final
concentrations, 10 to 50 nM). A two-step PCR with a combined annealing
and extension step was performed in a 9600 thermocycler (Perkin-Elmer,
Emeryville, Calif.). All cycles began with a DNA denaturation step for
5 min at 94°C. After this, cycles consisted of 30 s at 95°C
(denaturation) and 1 min and 30 s at 58°C (annealing and
extension) for 40 cycles. Primer extension at 72°C for 10 min
followed the final cycle.
Negative controls (no template DNA) were tested by using the same
reaction mixture under the amplification conditions described
above but
without template DNA. Positive standards for PCR used
1 ng of purified
DNA for each
Candida species to be
detected.
Quality control.
Each reaction was carried out in duplicate
or triplicate. One nanogram each of C. albicans and C. glabrata DNA was used as a positive control for each sample run.
Carryover contamination was reduced by using aerosol-resistant pipet
tips and separate laboratory areas for DNA sample preparation and PCR
amplification along with other standard contamination precautions
(9, 13).
Detection of PCR amplicon fluorescence.
Immediately
following the last PCR cycle or after storage at 4°C until the next
day, 40 µl from each PCR tube was transferred to a white, 96-well
microtitration plate (Dynatech, Chantilly, Va.). Forty microliters of
TE buffer (10 mM Tris, 1 mM EDTA [pH 8.0]) was used as a buffer
blank. The plate was then read on a LS 50B Luminescence Spectrometer
(Perkin-Elmer, Applied Biosystems, Inc., Foster City, Calif.) with a
microtitration plate reader attachment. An excitation wavelength of 488 nm was used and the emission wavelengths for the reporter dyes were as
follows: FAM, 518 nm; TET, 538 nm; and HEX, 556 nm. The emission
wavelength for the quencher dye (TAMRA) was 582 nm. A fluorescent data
management system that uses EXCEL-compatible macros was used for data
analysis (Perkin-Elmer, Applied Biosystems, Inc.).
Data analysis and interpretation.
Using the TaqMan data
worksheet and macro (Perkin-Elmer, Applied Biosystems, Inc.), the delta
RQ for each sample was automatically calculated. The delta RQ is
defined as an increase in the emission intensity ratio of the reporter
dye after release from the quencher dye on the fluorescent probe (RQ+)
minus the baseline emission intensity of the quenched reporter dye on
the intact fluorescent probe (RQ
), or delta RQ = (RQ+)
(RQ
), where RQ+ (PCR with target DNA) is equal to emission intensity
of reporter with DNA/emission intensity of quencher with DNA and RQ
(PCR without target DNA) is equal to emission intensity of reporter
without DNA/emission intensity of quencher without DNA. A threshold RQ
is calculated to ensure a statistically high confidence level (99%)
when the standard deviation (SD) obtained from triplicate,
no-DNA-template controls is used.
We used the multicomponent data program to interpret PCR results when
using multiple probes simultaneously. The multicomponent
data program
automatically displayed the results as "no DNA,"
DNA template 1, DNA template 2, or DNA template 3 when either
the TaqMan 3 Allele-Genotype Worksheet or the two-reporter multicomponent
worksheet
for the well plate reader software was used (Perkin-Elmer,
Applied
Biosystems, Inc.). The "no DNA" threshold was automatically
calculated from values 2 SDs above the mean for the negative controls
(value = 1.00). We established the cutoff value for a positive
probe result as 2 SDs above the mean delta RQ for negative control
values in PCRs with multiple probes. That is, in PCR A, a positive
result was defined as a delta RQ above 0.066 (2 SDs above the
mean for
the negative controls) for the CA-FAM probe, 0.126 for
the CT-TET
probe, and 0.190 for the CP-HEX probe. Similarly, in
PCR B, a positive
result was defined as a delta RQ above 0.034
(2 SDs above the mean for
the negative controls) for the CG-FAM
probe and above 0.078 for the
CK-TET probe. For the All-CAN-TET
probe, which detects all
Candida species and gives a significantly
higher value
relative to those given by the species-specific probes,
we used a
cutoff higher than the one that we used for the individual
species
probes. A value of 0.308 (4 SDs above the mean delta RQ
for all
negative controls tested) was used as the positive cutoff
value for
this
probe.
Statistical analysis.
Student's t test was used
to establish differences between test groups. A P value of
0.05 was considered significant.
 |
RESULTS |
Detection and identification of Candida species in
blood culture bottles using 5' exonuclease PCR and multiple fluorescent
probes.
The fluorescent probes used in this study are described in
Table 1. Probe sequences were modified from those described previously for the colorimetric detection of Candida species DNA
(9, 25) in order to optimize Tms and
thereby allow multiple probes to anneal to their respective target DNAs
with similar efficiencies. In addition, an all-Candida genus
probe (All-CAN-TET) was designed to detect all Candida
species tested.
The PCR assay could therefore use up to three fluorescent probes, with
the same excitation wavelength but different emission
wavelengths,
simultaneously in one reaction tube. In this manner,
we could group the
traditionally azole-sensitive species (
C. albicans,
C. tropicalis, and
C. parapsilosis using CA-FAM, CT-TET,
and CP-HEX
probes, respectively) to be identified in one reaction tube
(PCR
A) and the traditionally more azole-resistant
Candida
species
(
C. glabrata and
C. krusei using CG-FAM
and CK-TET probes, respectively)
to be identified in the second
reaction tube (PCR B) and then
use an all-
Candida genus
probe (All-CAN-TET) to simultaneously
detect all
Candida
species tested in a third reaction tube (PCR
C).
As shown in Table
2, fluorescent probes
were highly specific for the identification of the appropriate
Candida species.
C. albicans,
C. tropicalis, and
C. parapsilosis were each correctly
identified in PCR A,
C. glabrata and
C. krusei
were correctly
identified in PCR B, and all
Candida species
were detected by
the All-CAN-TET probe in PCR C. No cross-reactions
with other
Candida species or with samples from patients
with bacteremia
or with samples from blood culture bottles with no
growth were
observed (Table
2). Despite the coexistence of bacteria
with
Candida in five of the blood culture bottles from
patients with
candidemia (including
Enterococcus spp.
[
n = 4] and coagulase-negative
Staphylococcus [
n = 1]), no interference
with the PCR detection
of
Candida species was observed.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Detection and identification of Candida
species in positive blood cultures with multiple
fluorescent probesa
|
|
Two of the three samples from patients with mixed candidemias were
identified by PCR to contain both
C. glabrata and
C. albicans,
which was in agreement with the results of conventional
phenotypic
identification methods. One culture, identified by
conventional
phenotypic methods as containing both
C. glabrata and
C. albicans (Table
3), was identified as containing only
C. glabrata by PCR.
However, the patient from whom the
sample for culture was obtained
had multiple blood samples that were
culture positive for
C. glabrata but only one blood sample
that was culture positive for
C. albicans.
It is likely,
therefore, that the single positive
C. albicans culture
represents a contaminant that entered the sample during
routine
phenotypic identification procedures and was defined as
such for this
study.
Three cultures (one each of
C. glabrata,
C. tropicalis, and
C. parapsilosis) gave values below the
positive cutoff established
for each of the corresponding fluorescent
probes and were therefore
considered to be falsely negative. No
bacteria were recovered
from these samples, and therefore, the false
negativity could
not be explained by interference from coexisting
bacteria. These
same cultures had been previously tested by the
colorimetric PCR-enzyme
immunoassay (PCR-EIA) (
25) and were
correctly identified as
positive in that
system.
Thus, probes for
C. albicans,
C. tropicalis, and
C. parapsilosis (PCR A) and those for
C. glabrata
and
C. krusei (PCR B) rapidly
and correctly identified the
isolates in 58 (95.1%) of 61 clinical
blood cultures and the
All-CAN-TET probe (PCR C) detected 100%
of all
Candida
species in cultures, including cultures of samples
from patients with
mixed candidemias. The sensitivity and specificity
for the correct
detection of the appropriate
Candida species from
blood
cultures for PCR A (azole-sensitive species) were 91.9 and
100%,
respectively; those for PCR B (azole-resistant species)
were 96.3 and
100%, respectively; and those for PCR C (all
Candida species) were 100 and 100%,
respectively.
Specificity of the probe for all Candida species versus
specificities of probes for other fungi.
The All-CAN-TET probe was
further tested to determine its capacity to detect other
Candida species DNA without cross-reacting with other yeasts
or fungi. The All-CAN-TET probe reacted with purified DNA from all
Candida spp. tested, S. cerevisiae, A. fumigatus, and A. flavus, but it did not react with any
other fungal, bacterial, or human DNA tested (Table
4). The lower values obtained for the
detection of Aspergillus species DNA relative to those
obtained for the detection of Candida species DNA were
probably a reflection of sequence differences between these two genera
in the target DNA region (6). Specific
Aspergillus species and genus probes have now been developed
to differentiate Candida species and other fungi from
Aspergillus species (4, 6), and a probe for
S. cerevisiae has been shown to be species specific in
preliminary tests (8). These results have been reported
separately (4, 6, 8).
Sensitivity of fluorescent probes for detection of known numbers of
Candida blastoconidia.
We compared the results
obtained with fluorescent probes with those obtained by a colorimetric
PCR-EIA method developed in our laboratory (9). C. albicans B311 blastoconidia were introduced at concentrations of
0, 101, 102, 103, 104,
or 105 per 200 µl of BacT/Alert culture broth containing
whole rabbit blood (broth to rabbit blood ratio = 8:1). The
samples were then processed as described in Materials and Methods for
fluorescence detection or as described previously for colorimetric and
ethidium bromide detection of PCR products (9, 25). The
results of this comparison are presented in Table
5.
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Comparative sensitivity of DNA detection by fluorescent
probes, colorimetric PCR-EIA, and ethidium bromide staining
|
|
The mean delta RQ value for the All-CAN-TET probe for each 200-µl
sample was higher than that for the CA-FAM probe, as might
be predicted
from the results presented in Table
2. Although
the signal strength for
the All-CAN-TET probe was higher than
that for the CA-FAM probe, the
higher positive cutoff value used
for the All-CAN-TET probe resulted in
identical limits of sensitivity
for both probes (i.e., 10
2
cells per 200-µl sample or 1 cell per 2-µl sample;
P < 0.01 relative
to the results for control samples containing no
DNA). Similarly,
although the signal strength for the colorimetric
detection system
probe (CA-DIG) was lower than that for either the
All-CAN-TET
or the CA-FAM probe, the cutoff value defined the limit of
sensitivity
to be identical to that for the fluorescent probes. In
contrast,
ethidium bromide staining of agarose gels for the detection
of
the PCR products was a log less sensitive than either the
fluorescent
probe assay or the PCR-EIA method (i.e., 10
3
cells per 200-µl sample) (Table
5).
 |
DISCUSSION |
We developed a rapid and simple 5' exonuclease PCR method using
fluorescent DNA probes to identify from blood culture bottles the five
most medically important Candida species responsible for
bloodstream infections. Species identification time was reduced from
7 h by colorimetric PCR-EIA to 5 h by the 5' exonuclease assay. This was accomplished by elimination of the post-PCR
hybridization step and the incubation step necessary for the
colorimetric detection of the PCR product and by use of two-step rather
than three-step PCR cycling. In addition, a generic Candida
probe for the detection of all Candida species DNAs
simultaneously in one reaction tube was developed.
Although others have described enzymatic lysis methods for the direct
recovery of fungal DNA from whole blood (3, 7, 12), most
require initial lysis of erythrocytes and leukocytes with salts,
detergents, and/or proteinase K and multiple purification steps in
order to obtain adequate DNA in sufficiently pure form for successful
PCR amplification. Our laboratory also found that multiple purification
steps were required for optimum PCR amplification of fungal DNA from
whole blood (9). In order to circumvent the laborious,
time-consuming, and hazardous (i.e., phenol-chloroform) steps required
to obtain sufficient DNA from Candida cells recovered from
whole blood, we chose to isolate Candida DNA from positive BacT/Alert blood culture bottles instead. This strategy allowed (i)
inhibitors of PCR amplification to be diluted out by the BacT/Alert blood culture bottle medium, (ii) an additional "amplification" of
DNA by the normal growth of Candida cells in the culture
bottles, and (iii) the use of detergent, heat, and mechanical
disruption for the isolation of Candida species DNA without
the use of phenol-chloroform.
In addition, the method most commonly used to detect PCR amplicons is
gel electrophoresis and ethidium bromide staining either with or
without restriction enzyme digestion before visualization (3, 5,
11, 23). Southern blotting after gel electrophoresis adds another
degree of sensitivity and specificity (12, 27) but is
labor-intensive and can be hazardous and expensive if radioisotopically labeled probes are used. One investigator expanded on these techniques and used single-strand conformational polymorphisms to differentiate and detect fungal DNA (28). None of these methods, however, is easily adapted to the clinical setting. The fluorescent 5' exonuclease assay, on the other hand, is rapid, simple to perform, sensitive, and specific and does not require a pure culture for correct
species identification.
Probe mixtures were therefore designed for use in the 5' exonuclease
assay to discriminate typically fluconazole-sensitive Candida species (C. albicans, C. tropicalis, C. parapsilosis) from more innately
fluconazole-resistant species (C. glabrata, C. krusei); this allowed a reduction in the number of sample
manipulation steps that needed to be performed and the detection of up
to three Candida species in a single reaction tube.
Potentially, probe mixtures could be reformulated in any combination to
accommodate the known resistance profiles at a particular institution,
particularly now that regional differences in species distribution have
been shown to occur (21).
The fluorescent, species-specific probes designed in this study
detected and correctly identified Candida species DNA from 58 (95.1%) of 61 clinical blood culture bottles and gave no falsely positive results. Three samples that were positive by conventional methods and by colorimetric PCR-EIA were falsely negative by the fluorescent 5' exonuclease assay. Falsely negative results were not
caused by the coexistence of bacteria because these samples contained
no bacteria (and in other samples, in which bacteria coexisted with
Candida species, the fluorescent 5' exonuclease assay was
correctly positive). However, the probe sequences were slightly
modified from those reported previously (9, 25) to optimize
primer extension and to allow multiple probes to bind with similar
frequencies when they were admixed in one reaction tube. Therefore,
such slight modifications in the probe sequences may have resulted in
reduced target detection in the three falsely negative samples.
Alternatively, DNA samples were stored for longer times before being
tested by the fluorescent 5' exonuclease assay than by conventional
methods or the colorimetric PCR-EIA (up to 5 months), and this longer
storage may have resulted in some deterioration of the DNA target in
these few samples. On the other hand, the all-Candida genus
probe detected 100% of all Candida species DNA in all
samples and did not cross-react with bacterial, human, or other fungal
DNA with the exception of S. cerevisiae, A. fumigatus, and A. flavus DNA. Because the
all-Candida genus probe was designed from the more conserved
5.8S region of the rRNA gene (15) rather than the less
conserved ITS2 region, it is not surprising that some
cross-reactivities were observed. However, with the sample preparation
methods used in the present study, it is unlikely, although not
impossible, that DNA from A. fumigatus or A. flavus would be recovered from blood cultures (the filamentous
fungi are more resistant to breakage by the methods that we used [see reference 17 for a review]). Also, the values
obtained for samples containing Aspergillus species DNA were
much lower relative to those obtained for samples containing
Candida species DNA and probably reflect the divergence in
DNA sequence for these two genera in this region (4, 6). If
the differentiation of Candida species from cross-reacting
Aspergillus species and S. cerevisiae should be
needed, however, preliminary studies have shown that a probe designed
in our laboratory to differentiate S. cerevisiae from
C. glabrata is species specific (8), and generic
and species-specific probes have also been designed to detect and
differentiate A. fumigatus and A. flavus from
yeasts and other fungi (4, 6).
Currently, probe mixtures can be customized to identify up to three
Candida species in a single reaction tube. If additional fluorescent dyes that have similar excitation wavelengths but different
emission wavelengths from those used in the present study are
developed, possibly even greater numbers of probes can be designed to
detect more than three species in a single reaction tube (i.e.,
ideally, the simultaneous detection and differentiation of the five
major Candida species). Also, the advent of more
broad-spectrum antifungal agents (i.e., voriconazole), if proved to be
clinically efficacious against all medically important
Candida species, may allow a single determination with the
all-Candida generic probe to suffice (at least until
evidence of voriconazole resistance occurs). At present, this assay
significantly reduces the time required to identify definitively the
Candida species obtained from blood culture bottles and
should facilitate a more rapid and specific diagnosis, which would lead
to the implementation of more appropriately targeted antifungal drug therapy.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Mailstop G-11,
CDC, 1600 Clifton Rd., N.E., Atlanta, GA 30333. Phone: (404) 639-3098. Fax: (404) 639-3546. E-mail: cjm3{at}cdc.gov.
 |
REFERENCES |
| 1.
|
Abi-Said, D.,
E. Anassie,
O. Uzun,
I. Raad,
H. Pinkowski, and S. Vartivarian.
1997.
The epidemiology of hematogenous candidiasis caused by different Candida species.
Clin. Infect. Dis.
24:1122-1128[Medline].
|
| 2.
| Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. S. Tolson, T. Henderson, and W. J. Martone.
1991. Secular trends in nosocomial primary blood stream infections in
the United States, 1980-1989. Am. J. Med. 91(Suppl.
3B):86S-89S.
|
| 3.
|
Buchman, T. G.,
M. Rossier,
W. G. Merz, and P. Charache.
1990.
Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene.
Surgery
108:338-347[Medline].
|
| 4.
|
Choi, J. S.,
J. M. Westerman, and C. J. Morrison.
1998.
Rapid differentiation of filamentous fungi using species-specific DNA probes, abstr. C-288, p. 179.
In
Abstracts of the 98th General Meeting of the American Society for American Society for Microbiology, Washington, D.C.
|
| 5.
|
Crampin, A. C., and R. C. Matthews.
1993.
Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment.
J. Med. Microbiol.
39:233-238[Abstract/Free Full Text].
|
| 6.
|
de Aguirre, L. A.,
H. Vaishnav,
J. M. Westerman,
E. Reiss, and C. J. Morrison.
1997.
Rapid differentiation of Aspergillus species from other filamentous fungi and yeasts using species-specific DNA probes, abstr. 234, p. 161.
In
Abstracts of the 97th General Meeting of the American Society for American Society for Microbiology, Washington, D.C.
|
| 7.
|
Einsele, H.,
H. Hebart,
G. Roller,
J. Loffler,
I. Rothenhofer,
C. A. Muller,
R. A. Bowden,
J.-A. van Burik,
D. Engelhard,
L. Kanz, and U. Schumacher.
1997.
Detection and identification of fungal pathogens in blood by using molecular probes.
J. Clin. Microbiol.
35:1353-1360[Abstract].
|
| 8.
|
Elie, C. M.,
T. J. Lott,
E. Reiss, and C. J. Morrison.
1998.
Rapid identification of Candida species with species-specific DNA probes.
J. Clin. Microbiol.
36:3260-3265[Abstract/Free Full Text].
|
| 9.
|
Fujita, S.,
B. A. Lasker,
T. J. Lott,
E. Reiss, and C. J. Morrison.
1995.
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood.
J. Clin. Microbiol.
33:962-969[Abstract].
|
| 10.
|
Holland, P. M.,
R. D. Abramson,
R. Watson, and D. H. Gelfand.
1991.
Detection of specific polymerase chain reaction product by utilizing the 5' to 3' exonuclease activity of Thermus aquaticus DNA polymerase.
Proc. Natl. Acad. Sci. USA
88:7276-7280[Abstract/Free Full Text].
|
| 11.
|
Hopfer, R. L.,
P. Walden,
S. Setterquist, and W. E. Highsmith.
1993.
Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis.
J. Med. Vet. Mycol.
31:65-75[Medline].
|
| 12.
|
Jordan, J.
1994.
PCR identification of four medically important Candida species by using a single primer pair.
J. Clin. Microbiol.
32:2962-2967[Abstract/Free Full Text].
|
| 13.
|
Kwok, S., and R. Higuichi.
1989.
Avoiding false positives with PCR.
Nature (London)
39:237-238.
|
| 14.
|
Lee, L. G.,
C. R. Connell, and W. Bloch.
1993.
Allelic discrimination by nick-translation PCR with fluorogenic probes.
Nucleic Acids Res.
21:3761-3766[Abstract/Free Full Text].
|
| 15.
|
Lott, T. J.,
R. J. Kuykendall, and E. Reiss.
1993.
Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species.
Yeast
2:1199-1206.
|
| 16.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 17.
| Morrison, C. J., C. M. Elie, B. A. Skaggs, S.-I. Fujita, and J. H. Shin. Recovery of
yeast DNA from clinical samples. Methods Mol. Biol., in press.
|
| 18.
|
Nyugen, M. H.,
J. E. Peacock,
A. J. Morris,
D. C. Tanner,
M. L. Nyugen,
D. R. Snydman,
M. M. Wagener,
M. G. Rinaldi, and V. L. Yu.
1996.
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Am J. Med.
100:617-623[Medline].
|
| 19.
|
Odds, F. C., and R. Bernaerts.
1994.
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
J. Clin. Microbiol.
32:1923-1929[Abstract/Free Full Text].
|
| 20.
| Pfaller, M. A. 1996. Nosocomial candidiasis:
emerging species, reservoirs, and modes of transmission. Clin. Infect.
Dis. 22(Suppl. 2):S89-S94.
|
| 21.
|
Pfaller, M. A.,
R. N. Jones,
S. A. Messer,
M. B. Edmond,
R. P. Wenzel, and the SCOPE Participant Group.
1998.
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program.
Diagn. Microbiol. Infect. Dis.
30:121-129[Medline].
|
| 22.
|
Price, M. F.,
M. T. LaRocco, and L. O. Gentry.
1994.
Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period.
Antimicrob. Agents Chemother.
38:1422-1424[Abstract/Free Full Text].
|
| 23.
|
Rand, K. H.,
H. Houck, and M. Wolff.
1994.
Detection of candidemia by polymerase chain reaction.
Mol. Cell. Probes
8:215-222[Medline].
|
| 24.
|
Rex, J. H.,
M. A. Pfaller,
R. J. Hollis, and R. P. Wenzel.
1995.
Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia.
Antimicrob. Agents Chemother.
39:40-44[Abstract].
|
| 25.
|
Shin, J. H.,
F. S. Nolte, and C. J. Morrison.
1997.
Rapid identification of Candida species from blood culture using a clinically useful polymerase chain reaction (PCR) method.
J. Clin. Microbiol.
35:1454-1459[Abstract].
|
| 26.
|
Sullivan, D., and D. Colemen.
1998.
Candida dubliniensis: characteristics and identification.
J. Clin. Microbiol.
36:329-334[Free Full Text].
|
| 27.
|
Verweij, P. E.,
J.-P. Latge,
A. J. M. M. Rijs,
W. J. G. Melchers,
B. E. De Pauw,
J. A. A. Hookamp-Korstanje, and J. F. G. M. Meis.
1995.
Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
J. Clin. Microbiol.
33:3150-3153[Abstract].
|
| 28.
|
Walsh, T. J.,
A. Francesconi,
M. Kasai, and S. J. Chanock.
1995.
PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi.
J. Clin. Microbiol.
33:3216-3220[Abstract].
|
| 29.
|
Warren, N. G., and K. C. Hazen.
1995.
Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737.
In
P. R. Murray, E. J. Barton, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 30.
|
White, T. J.,
T. D. Burns,
S. B. Lee, and J. W. Taylor.
1990.
Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322.
In
M. A. Innis, D. H. Helfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols. Academic Press, Inc., San Diego, Calif.
|
| 31.
|
Wingard, J. R.
1995.
Importance of Candida species other than C. albicans as pathogens in oncology patients.
Clin. Infect. Dis.
20:115-125[Medline].
|
| 32.
|
Wingard, J. R.,
W. G. Merz,
M. G. Rinaldi,
T. R. Johnson,
J. E. Karp, and R. Saral.
1991.
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
N. Engl. J. Med.
325:1274-1315[Abstract].
|
| 33.
|
Wingard, J. R.,
W. G. Merz,
W. G. Rinaldi,
C. B. Miller,
J. E. Karp, and R. Saral.
1993.
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Antimicrob. Agents Chemother.
37:1847-1849[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, January 1999, p. 165-170, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Metwally, L., Hogg, G., Coyle, P. V., Hay, R. J., Hedderwick, S., McCloskey, B., O'Neill, H. J., Ong, G. M., Thompson, G., Webb, C. H., McMullan, R.
(2007). Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR. J Med Microbiol
56: 964-970
[Abstract]
[Full Text]
-
Innings, A., Ullberg, M., Johansson, A., Rubin, C. J., Noreus, N., Isaksson, M., Herrmann, B.
(2007). Multiplex Real-Time PCR Targeting the RNase P RNA Gene for Detection and Identification of Candida Species in Blood. J. Clin. Microbiol.
45: 874-880
[Abstract]
[Full Text]
-
Schabereiter-Gurtner, C., Selitsch, B., Rotter, M. L., Hirschl, A. M., Willinger, B.
(2007). Development of Novel Real-Time PCR Assays for Detection and Differentiation of Eleven Medically Important Aspergillus and Candida Species in Clinical Specimens. J. Clin. Microbiol.
45: 906-914
[Abstract]
[Full Text]
-
Alcoba-Florez, J., del Pilar Arevalo, M., Gonzalez-Paredes, F. J., Cano, J., Guarro, J., Perez-Roth, E., Mendez-Alvarez, S.
(2005). PCR Protocol for Specific Identification of Candida nivariensis, a Recently Described Pathogenic Yeast. J. Clin. Microbiol.
43: 6194-6196
[Abstract]
[Full Text]
-
de Aguirre, L., Hurst, S. F., Choi, J. S., Shin, J. H., Hinrikson, H. P., Morrison, C. J.
(2004). Rapid Differentiation of Aspergillus Species from Other Medically Important Opportunistic Molds and Yeasts by PCR-Enzyme Immunoassay. J. Clin. Microbiol.
42: 3495-3504
[Abstract]
[Full Text]
-
Maaroufi, Y., Ahariz, N., Husson, M., Crokaert, F.
(2004). Comparison of Different Methods of Isolation of DNA of Commonly Encountered Candida Species and Its Quantitation by Using a Real-Time PCR-Based Assay. J. Clin. Microbiol.
42: 3159-3163
[Abstract]
[Full Text]
-
Maaroufi, Y., De Bruyne, J.-M., Duchateau, V., Georgala, A., Crokaert, F.
(2004). Early Detection and Identification of Commonly Encountered Candida Species from Simulated Blood Cultures by Using a Real-Time PCR-Based Assay. J. Mol. Diagn.
6: 108-114
[Abstract]
[Full Text]
-
Selvarangan, R., Bui, U., Limaye, A. P., Cookson, B. T.
(2003). Rapid Identification of Commonly Encountered Candida Species Directly from Blood Culture Bottles. J. Clin. Microbiol.
41: 5660-5664
[Abstract]
[Full Text]
-
Christensen, J. E., Stencil, J. A., Reed, K. D.
(2003). Rapid Identification of Bacteria from Positive Blood Cultures by Terminal Restriction Fragment Length Polymorphism Profile Analysis of the 16S rRNA Gene. J. Clin. Microbiol.
41: 3790-3800
[Abstract]
[Full Text]
-
Maaroufi, Y., Heymans, C., De Bruyne, J.-M., Duchateau, V., Rodriguez-Villalobos, H., Aoun, M., Crokaert, F.
(2003). Rapid Detection of Candida albicans in Clinical Blood Samples by Using a TaqMan-Based PCR Assay. J. Clin. Microbiol.
41: 3293-3298
[Abstract]
[Full Text]
-
Bautista-Munoz, C., Boldo, X. M., Villa-Tanaca, L., Hernandez-Rodriguez, C.
(2003). Identification of Candida spp. by Randomly Amplified Polymorphic DNA Analysis and Differentiation between Candida albicans and Candida dubliniensis by Direct PCR Methods. J. Clin. Microbiol.
41: 414-420
[Abstract]
[Full Text]
-
Fujita, S.-I., Senda, Y., Nakaguchi, S., Hashimoto, T.
(2001). Multiplex PCR Using Internal Transcribed Spacer 1 and 2 Regions for Rapid Detection and Identification of Yeast Strains. J. Clin. Microbiol.
39: 3617-3622
[Abstract]
[Full Text]
-
Guiver, M, Levi, K, Oppenheim, B A
(2001). Rapid identification of candida species by TaqMan PCR. J. Clin. Pathol.
54: 362-366
[Abstract]
[Full Text]
-
Martin, C., Roberts, D., van der Weide, M., Rossau, R., Jannes, G., Smith, T., Maher, M.
(2000). Development of a PCR-Based Line Probe Assay for Identification of Fungal Pathogens. J. Clin. Microbiol.
38: 3735-3742
[Abstract]
[Full Text]
-
Park, S., Wong, M., Marras, S. A. E., Cross, E. W., Kiehn, T. E., Chaturvedi, V., Tyagi, S., Perlin, D. S.
(2000). Rapid Identification of Candida dubliniensis Using a Species-Specific Molecular Beacon. J. Clin. Microbiol.
38: 2829-2836
[Abstract]
[Full Text]
-
Henry, T., Iwen, P. C., Hinrichs, S. H.
(2000). Identification of Aspergillus Species Using Internal Transcribed Spacer Regions 1 and 2. J. Clin. Microbiol.
38: 1510-1515
[Abstract]
[Full Text]